Brief: Prime Medicine Shares Open At Premium of 11.6% in Nasdaq Debut VS IPO Price
20/10/2022 18:11
Oct 20 (Reuters) - PRIME MEDICINE INC SHARES OPEN AT $18.97 IN NASDAQ DEBUT VERSUS IPO PRICE OF $17.00/SHARE Source text for Eikon: ID: Further company coverage: PRME.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease